Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04601402 |
|---|---|
| Brief Title: | GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy |
| First Submitted : | October 13, 2020 |
| First Submitted that Met QC Criteria : | October 19, 2020 |
| First Posted : | October 23, 2020 |
| Last Update Submitted that Met QC Criteria : | October 19, 2020 |
| Last Update Posted : | October 23, 2020 |